Trove
Sign In Sign Up

AwarePoint

Organization
Mentions
6
Relationships
1
Events
0
Documents
3
Also known as:
AwarePoint Corporation
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
1 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
organization New Leaf
Financial
5
1
View
No events found for this entity.

HOUSE_OVERSIGHT_024049.jpg

This document appears to be page 38 of a confidential investment memorandum for New Leaf Ventures (specifically fund NLV-III). It outlines the firm's 'Information Convergence' investment strategy, focusing on healthcare technology solutions that address inefficiencies and rising costs in the U.S. healthcare system. It cites 'AwarePoint' (from fund NLV-II) as a case study. The document bears a House Oversight Committee Bates stamp, suggesting it was part of a document production for a congressional investigation, likely related to the financial networks surrounding Jeffrey Epstein, though Epstein is not explicitly named on this specific page.

Investment memorandum / fund strategy document (page 38)
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024023.jpg

This document is a page from a corporate prospectus or due diligence report (marked Confidential, House Oversight) detailing the professional biographies of three Managing Directors at New Leaf (presumably New Leaf Venture Partners): Jeani Delagardelle, Ron Hunt, and Vijay Lathi. All three were previously associated with Sprout Group. The document lists their educational backgrounds and extensive board memberships across various pharmaceutical and medical technology companies.

Corporate prospectus / biography page / due diligence report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024100.jpg

This document is a confidential financial appendix (Appendix 1) labeled 'Listing of Investments by Fund' for New Leaf Ventures II, L.P., dated March 31, 2014. It details the financial performance of numerous healthcare, therapeutic, and diagnostic companies in the fund's portfolio, split into realized/partially realized and unrealized investments. The document bears a House Oversight Committee stamp and a confidential control number, indicating it is part of a congressional investigation.

Financial report / investment schedule
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search